Literature DB >> 12161004

The peroxisome proliferator-activated receptor alpha (PPARalpha): role in hepatocarcinogenesis.

Frank J Gonzalez1.   

Abstract

The peroxisome proliferator-activated receptor alpha (PPARalpha) is a member of the nuclear receptor superfamily and mediates most of the known biological effects of peroxisome proliferators. The latter represents a large group of chemicals that include the fibrate hyperlipidemic drugs, the pthalate plasticizers, various solvents and degreasing agents, and endogenous hormones and fatty acids. Peroxisome proliferators are classical members of the nongenotoxic group of chemical carcinogens that do not require metabolic activation to electrophiles in order to exert their harmful effects. These chemicals are of particular concern to regulatory agencies since they can only be detected by long-term carcinogen bioassays using rodents. The mechanism of the carcinogenic action of peroxisome proliferators is beginning to emerge. PPARalpha-null mice are resistant to hepatocarcinogenesis indicating that this receptor is necessary for cancer. However, recent studies indicate that Kupffer cells, in a PPARalpha independent manor, are required for the major effects of peroxisome proliferators on cell proliferation. An interaction between PPARalpha and estrogen carcinogenesis has also been elucidated. Copyright 2002 Elsevier Science Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161004     DOI: 10.1016/s0303-7207(02)00098-9

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  16 in total

Review 1.  Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Shilu Mathew; Hany Abdel-Hafiz; Abbas Raza; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-08

Review 2.  Cytochrome P450 and xenobiotic receptor humanized mice.

Authors:  Frank J Gonzalez; Ai-Ming Yu
Journal:  Annu Rev Pharmacol Toxicol       Date:  2006       Impact factor: 13.820

Review 3.  Mouse models in liver cancer research: a review of current literature.

Authors:  Martijn W H Leenders; Maarten W Nijkamp; Inne H M Borel Rinkes
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

Review 4.  Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages.

Authors:  Lucía Fuentes; Tamás Roszer; Mercedes Ricote
Journal:  Mediators Inflamm       Date:  2010-05-20       Impact factor: 4.711

Review 5.  Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma.

Authors:  Kwang Il Kim; Hye Kyung Chung; Ju Hui Park; Yong Jin Lee; Joo Hyun Kang
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

6.  Clinically relevant concentrations of di (2-ethylhexyl) phthalate (DEHP) uncouple cardiac syncytium.

Authors:  Nikki Gillum; Zaruhi Karabekian; Luther M Swift; Ronald P Brown; Matthew W Kay; Narine Sarvazyan
Journal:  Toxicol Appl Pharmacol       Date:  2009-01-22       Impact factor: 4.219

Review 7.  Role of nuclear receptors in breast cancer stem cells.

Authors:  Alessio Papi; Marina Orlandi
Journal:  World J Stem Cells       Date:  2016-03-26       Impact factor: 5.326

8.  Tissue expression of PPAR-α isoforms in Scophthalmus maximus and transcriptional response of target genes in the heart after exposure to WY-14643.

Authors:  R Urbatzka; S Galante-Oliveira; E Rocha; L F C Castro; I Cunha
Journal:  Fish Physiol Biochem       Date:  2012-12-25       Impact factor: 2.794

9.  Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid.

Authors:  Jonathan M Maher; Lauren M Aleksunes; Matthew Z Dieter; Yuji Tanaka; Jeffrey M Peters; Jose E Manautou; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2008-08-29       Impact factor: 4.849

10.  Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers.

Authors:  Malkhey Verma; Hans-Joerg Martin; Wahajul Haq; Timothy R O'Connor; Edmund Maser; Ganesaratnam K Balendiran
Journal:  Eur J Pharmacol       Date:  2008-02-05       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.